Qube Research & Technologies (QRT)’s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant MBAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-25,119
Closed -$254K 3064
2021
Q2
$254K Buy
+25,119
New +$251K ﹤0.01% 1676

Other funds holding MBAC.U

Qube Research & Technologies (QRT)'s MBAC.U Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant (MBAC.U) in Q3 2021, closing a stake of 25,119 shares — an estimated $254K sold.

Qube Research & Technologies (QRT) first reported a position in MBAC.U in Q2 2021 and held it in 1 quarter. The position peaked at $254K in Q2 2021. 19 funds tracked by Wall St. Rank hold MBAC.U as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 25,119 M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant shares in Q3 2021, an estimated $254K.
  • Qube Research & Technologies (QRT) first reported a position in M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q2 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position peaked at $254K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.